Background
==========

Cardiovascular diseases (CVDs) such as ischemic heart disease and stroke are the major causes of death in many countries \[[@b1-medscimonit-25-3573],[@b2-medscimonit-25-3573]\]. In addition to conventional cardiovascular risk factors such as obesity, dyslipidemia, hypertension, and smoking, there is growing evidence that chronic psychosocial stress plays a role in the pathogenesis of CVD \[[@b3-medscimonit-25-3573]\]. Previous studies \[[@b4-medscimonit-25-3573],[@b5-medscimonit-25-3573]\] demonstrated that different psychosocial factors, including job stress, anxiety, depression, social isolation, and some personality traits are associated with increased CVD risk.

The major challenge of studies investigating the effect of chronic stress on the prevalence of CVD is the selection of method for the evaluation of psychosocial stress level. Stress can be assessed using subjective and objective methods, including self-reported questionnaires and stress biomarkers measured in different matrices \[[@b6-medscimonit-25-3573]--[@b10-medscimonit-25-3573]\]. Since a response to the perceived psychosocial stress results in activation of the hypothalamic-pituitary-adrenal axis (HPA), the high level of its end-product, cortisol, is frequently used as a biomarker of psychological stress. Investigation of saliva, serum, and urine provides information about the cortisol production for up to 24 h, while long-term integrated hormone secretion can be assessed by measuring cortisol concentration in scalp hair, as each centimeter of scalp hair represents 1 month of past cortisol exposure \[[@b7-medscimonit-25-3573],[@b10-medscimonit-25-3573]\]. Another approach to evaluating chronic stress level is the calculation of allostatic load (AL) index, which is defined as a measure of "wear and tear" on the body and represents a dysfunction of different physiological systems involved in response to the perturbations caused by a stressor \[[@b11-medscimonit-25-3573]\].

Since prior studies \[[@b12-medscimonit-25-3573]\] showed that chronic stress is associated with 40--60% higher risk of CVD, it is hypothesized that glucocorticoids (cortisol in humans) serve as mediators of relations between stress and CVD. Cortisol exerts its biological effects by modulating lipid metabolism, as it promotes lipolysis in the peripheral fat depots and increases lipogenesis in visceral fat tissue \[[@b13-medscimonit-25-3573],[@b14-medscimonit-25-3573]\]. In addition, cortisol regulates blood pressure by acting on renal mineralocorticoid receptors, which results in salt and water retention and consequently increased plasma volume \[[@b13-medscimonit-25-3573],[@b15-medscimonit-25-3573]\]. Also, sustained HPA axis activation and cortisol exposure lead to glucocorticoid-resistance, which is associated with decreased capability of cortisol to suppress proinflammatory cytokine (IL-1β, IL-6, TNF-α, INF-γ) production and induce antiinflammatory cytokine (IL-4, IL-10, IL-13) secretion \[[@b16-medscimonit-25-3573]\]. Moreover, it has been shown that chronic psychosocial stress induced activation of sympathetic nervous system results in endothelial dysfunction due to indirect activation of NADPH oxidase, which catalyzes the generation of reactive oxygen species \[[@b17-medscimonit-25-3573],[@b18-medscimonit-25-3573]\]. Additionally, it is speculated that psychosocial stress is associated with increased platelet activation and reactivity. Matsuhisa et al. \[[@b19-medscimonit-25-3573]\] reported a positive association between chronic, but not acute, stress and agonist-induced (thrombin and adenosine diphosphate) platelet aggregation biomarkers. Nonetheless, the majority of studies \[[@b19-medscimonit-25-3573],[@b20-medscimonit-25-3573]\] were conducted using animal models or focused mainly on the effect of acute stress on platelet activation biomarkers.

Since there is growing evidence that chronic stress-induced long-term cortisol exposure concentration is related to obesity, metabolic syndrome, and CVD, the objective of our study was to analyze the association between HCC and the prevalence of traditional cardiovascular risk factors, including dyslipidemia, smoking, hypertension, and obesity. Due to the importance of inflammation in the pathogenesis of CVD, we investigated the relationship between HCC and systemic inflammation biomarkers, including white blood cell (WBC) count, neutrophil percentage, and C-reactive protein (CRP), as well as a relatively new biomarker, cyclophilin A (CypA), which presumably contributes to cardiovascular inflammation. Finally, we evaluated chronic stress level by calculating the allostatic load (AL) index, which represents dysregulation of multiple systems likely involved in the pathogenesis of cardiovascular disease, and we investigated the association between AL index and HCC values.

Material and Methods
====================

Study population
----------------

The study included 163 apparently healthy men (age, 24--55 years), who were recruited consecutively from the Outpatient Department of Vilnius University Hospital Santaros Klinikos. Participants completed a self-reported questionnaire on sociodemographic and lifestyle characteristics, including age, marital status, monthly income, smoking status, and physical activity. All anthropometric parameters (height, weight, waist circumference), resting arterial blood pressure (systolic and diastolic), and heart rate values were assessed by trained personnel. The study protocol was approved by the Lithuanian Bioethics Committee (No. 15820-15-807-319). All participants provided written informed consent before entering the study.

Biochemical analyses
--------------------

All blood samples were collected under fasting conditions and were analyzed in the Centre of Laboratory Medicine of Vilnius University Hospital Santaros Klinikos. Specifically, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triacylglycerol (TAG), glucose, and high-sensitivity CRP levels in blood serum were determined using routine methods (Architect ci8200, Abbott, USA). The quantitative determination of CypA in blood serum was made using enzyme-linked immunoassay (Gemini, Stratec Biomedical, Germany) with reagents from LDN® (Nordhorn, Germany). Non-high-density lipoprotein cholesterol (non-HDL-C) concentration was calculated by subtracting the HDL-C value from a TC.

Hair sampling, preparation, and analysis
----------------------------------------

HCC was determined from the most proximal segment of the outer 3 cm of scalp hair, representing the 3 months prior to sampling grown hair. The hair samples were stored at room temperature in envelopes until analysis.

Samples were prepared and analyzed using the modified Raul et al. \[[@b21-medscimonit-25-3573]\] and De Palo et al. \[[@b22-medscimonit-25-3573]\] methods. Firstly, 20--50 mg of hair sample was weighed and finely cut with scissors, then washed twice in isopropanol and put into polypropylene tubes. Later, hair samples were incubated in 2 ml Sorensen buffer for 16 h at 40°C in the presence of 10 ng 6α-methylprednisolone as an internal standard. Each sample then was transferred to the solid-phase extraction column, which was rinsed with the sequence of solvents \[[@b22-medscimonit-25-3573]\]. The eluates were evaporated under a stream of nitrogen gas and resuspended with 100 μl high-performance liquid chromatography (HPLC) in mobile phase.

Chromatographic separation was performed on a HPLC system (Shimadzu Nexera X2). A 10-μl sample was injected on the HPLC column (Zorbax Eclipse XDB -- C8, 4.6×150 mm, 5 μm). The chromatographic isocratic separation was carried out with a binary mobile phase of acetonitrile and water (2: 3, v/v), and UV light absorbance was measured at 245 nm wavelength. The average retention time of the cortisol was 4.12 min.

Determination of malondialdehyde (MDA) concentration in blood serum
-------------------------------------------------------------------

Samples were prepared and analyzed according to the methodology of Khoschosorur et al. \[[@b23-medscimonit-25-3573]\] using the HPLC method with fluorescence detection. Chromatographic separation was performed on the HPLC system (Shimadzu Nexera X2). A 20-μl sample was injected on the HPLC column (Agilent Poroshell 120 EC--C18, 3×100 mm, 2.7 μm). The chromatographic isocratic separation was carried out with a binary mobile phase of methanol and 50 mM phosphate buffer, pH 6.8 (2: 3, v/v). Fluorescence detection was performed at 230 nm excitation and 430 nm emission wavelengths. The average retention time of the malondialdehyde-thiobarbituric acid adduct was 1.63 min.

Determination of blood serum total antioxidant activity by ferric-reducing antioxidant power (FRAP) assay
---------------------------------------------------------------------------------------------------------

Total antioxidant capacity was assessed by using FRAP assay using a slightly modified method by Benzie et al. \[[@b24-medscimonit-25-3573]\]. The FRAP reagent was prepared by mixing acetate buffer (pH 3.6), TPTZ (2,4,6-tripyridyl-s-triazine) and FeCl~3~·6H~2~O solutions in the ratio 10: 1: 1. 100 μl of the blood serum, 2 ml of the FRAP reagent, and 900 μl of distilled water, incubated for 30 min at room temperature, and the absorbance was measured at 593 nm wavelength (Shimadzu UV -- 1601, Japan). All serum samples were analyzed in triplicate. FRAP value was determined from the obtained calibration curves using standard FeSO~4~ solutions. Results are expressed in μmol Fe^2+^/l.

Evaluation of platelet function
-------------------------------

Platelet function was measured within 10 min after blood collection, using flow cytometry (BD FACSCanto, BD Biosciences, USA). Data were analyzed using BD FACS Diva software (version 6.1.2). Two tubes were stained with CD42a-PerCP-Cy5.5 (glycoprotein IX) and CD61-APC (integrin beta-3), which are both platelet-specific markers. A combination of forward and side scatter characteristics, together with positive expression CD42a and CD61, was used to identify platelets. One tube was additionally stained with CD63-PE (a platelet alpha granule integrin), which is a marker of platelet degranulation. Another tube was additionally stained with PAC-1-FITC (platelet activation complex-1), which reacts with activated glycoprotein IIb/IIIa (integrin a2iib3) and represents platelet activation/aggregation status. Platelet agonists were added to the tubes to elicit platelet activation: TRAP (thrombin receptor-activating peptide) in the tube stained with CD63, and ADP (adenosine diphosphate) in the tube with PAC-1. The results are presented as the percentage of platelets expressing the activation marker (CD63 and PAC-1) after agonist stimulation.

Calculation of allostatic load (AL) indices
-------------------------------------------

Although there is a general agreement to include cardiovascular, metabolic, and immune systems in the calculation of allostatic load index, there is a huge variation in the selection of biomarkers and determination of high-risk cut-off point values for individual biomarker \[[@b27-medscimonit-25-3573]\]. In this study, AL indices were calculated as a sum of 5 separate physiological system (cardiovascular, metabolic, immune, oxidative stress, and platelet activation) risk scores (SRS). In total, 18 biomarkers were used for the calculation of AL indices. Contrary to other studies, we included oxidative stress and platelet activation biomarkers in the estimation of the AL index as the potential contributors to chronic stress induced allostatic load. Moreover, a relatively new inflammatory biomarker, CypA, was incorporated along with traditional biomarkers (CRB, WBC count, and neutrophil percentage) in the calculation of immune system risk score. However, sympathetic nervous system parameters such as urine epinephrine or norepinephrine levels, commonly used in previous studies, were not available in our study.

Each biomarker was dichotomized into high- and low-risk values: 1 point was given if the biomarker was in the high-risk range and 0 if not. Thus, the higher AL index value indicates the greater effect of chronic stress exposure on physiologic dysregulation \[[@b25-medscimonit-25-3573]--[@b27-medscimonit-25-3573]\]. To determine the high-risk cut-off point values, the study sample was divided into quartiles and high risk was defined as greater than the 75^th^ percentile for all variables except for HDL-C and FRAP measures. For these variables, high risk was defined as a value less than the 25^th^ percentile \[[@b27-medscimonit-25-3573]\]. The SRS was in the range from 0 to 7, depending on the number of biomarkers in each system, while the overall AL index ranged from 0 to 18.

Statistical analysis
--------------------

Statistical analysis was performed with R version 3.4.1.2. Quantitative variables are presented as mean ± standard deviation (SD) for normally distributed or median (interquartile range) (IQR) for non-normally distributed variables. For categorical variables, absolute and relative frequencies were calculated. As not all variables were distributed along the normal distribution, Spearman's rank coefficient was used to quantify the strength of the correlation between HCC and inflammation, oxidative stress, or platelet activation biomarkers. The comparisons of HCC among the 4 different groups based on the number of cardiovascular risk factors were performed using nonparametric Kruskal-Wallis analysis followed by the Mann-Whitney U test with Bonferroni correction. The latter test was also used for the comparison of allostatic load index between 2 hair cortisol concentration groups. The level of statistical significance was set at 0.05 for two-tailed testing.

Results
=======

Sample characteristics
----------------------

Sociodemographic and lifestyle characteristics of the study sample are shown in [Table 1](#t1-medscimonit-25-3573){ref-type="table"}. Overall, the median (IQR) age was 39 (16.5) years. Self-reported data showed that most subjects were non-smokers (83.1%), engaged in sedentary work (69.4%), and were physically active outside working hours (81.8%). Descriptives of anthropometric and cardiometabolic indicators, neuroendocrine, inflammation, oxidative stress, and platelet activation biomarkers of the study sample are shown in [Table 2](#t2-medscimonit-25-3573){ref-type="table"}. The median values of lipid and glucose metabolism biomarkers (TC, HDL-C, TAG, and fasting glucose), except for LDL-C, were within the current reference range of a general population.

The median (IQR) hair cortisol concentration was 46.2 (119.3) ng/g.

Hair cortisol concentration and cardiovascular risk factor
----------------------------------------------------------

To determine the association between the hair cortisol concentration and cardiovascular risk factors, we divided the study participants into 2 groups according to the prevalence of the major risk factors, including obesity, smoking, hypertension, and dyslipidemia. The manifestation of these risk factors was evaluated using the latest update of the European Guidelines on cardiovascular disease prevention in clinical practice prepared by the European Society of Cardiology \[[@b28-medscimonit-25-3573]\].

The results of this study showed that participants with higher-than-recommended TC (≥5.20 mmol/l), LDL-C (≥3.00 mmol/l), and non-HDL-C (≥3.80 mmol/l) values had a significantly higher HCC median (IQR) compared to those with normal lipid profile (34.28(114.01) ng/g *vs.* 64.69(131.80) ng/g, p=0.012, 38.14(77.22) ng/g *vs.* 55.12(141.72) ng/g, p=0.010, and 36.82 (123.82) ng/g *vs.* 54.68 (113.28) ng/g, p=0.041, respectively). However, there were no significant differences of HCC between normal and higher-than-recommended TAG (\<1.70 mmol/l *vs.* ≥1.70 mmol/l) or lower-than-recommended (\>1.00 mmol/l *vs.* ≤1.00 mmol/l) HDL-C level groups (44.38(117.32) ng/g *vs.* 54.68(119.88) ng/g, p=0.306, 41.04 (117.77) ng/g *vs.* 69.79 (155.05) ng/g, p=0.351, respectively). Also, participants with greater BMI (\>25.00 kg/m^2^) and WC (94 cm) values showed significantly higher hair cortisol concentration median (IQR) values than subjects with normal BMI (≤25 kg/m^2^) and WC (\<94 cm) results (32.13(83.25) ng/g *vs.* 55.12(141.72) ng/g, p=0.0189, 34.98(88.41) ng/g *vs.* 77.16(152.14) ng/g, p=0.007, respectively). Although the difference in HCC between hypertensive (≥140/90 mmHg) and non-hypertensive (\<140/90 mmHg) participants did not reach statistical significance, the tendency of higher HCC median (IQR) among the hypertensive participants was observed (67.24(120.50) ng/g *vs.* 37.78(111.52) ng/g, p=0.052). Similarly, there was no significant difference in HCC median (IQR) between the smokers and non-smokers (64.69(130.74) ng/g *vs.* 39.82(102.50) ng/g, p=0.113).

Due to the well-known synergistic effect of multiple cardiovascular risk factors, we divided the entire study sample into 4 groups according to the prevalence of cardiovascular risk factors: higher-than-recommended LDL-C concentration and WC value, smoking, and hypertension. The results indicated that 30.4% of partcipants had 1 risk factor, 27.2% had 2 risk factors, 15.8% had 3 or 4 risk factors, and 26.6% of subjects showed no evidence of increased cardiovascular risk. The comparisons among the 4 groups showed a statistically significant trend of increase in HCC with increasing cardiovascular risk, with a statistically significant difference between the first and the third (no risk factors *vs.* 2 risk factors), and between the first and the fourth (no risk factors *vs.* ≥3 risk factors) groups ([Figure 1](#f1-medscimonit-25-3573){ref-type="fig"}).

Hair cortisol concentration and inflammatory, oxidative stress, and platelet activation biomarkers
--------------------------------------------------------------------------------------------------

Our results demonstrated a weak positive correlation between HCC and neutrophil percentage, but no associations were found between HCC and other inflammatory biomarkers such as CRP, CyPA, and WBC count. In addition, no relationship was observed between the HCC and oxidative stress (MDA, FRAP) or platelet activation (CD63+ and PAC-1+ platelets stimulated with TRAP and ADP, respectively) biomarkers. Correlations between the HCC and inflammation, oxidative stress, and platelet activation biomarkers are shown in [Table 3](#t3-medscimonit-25-3573){ref-type="table"}.

Allostatic load and hair cortisol concentration
-----------------------------------------------

To investigate the association between the HCC and 5 distinct systems (cardiovascular, metabolic, immune, oxidative stress, and platelet activation) risk scores or allostatic load index values, we divided the entire study sample into 2 groups according to HCC median (HCC ≤46.182 ng/g *vs*. HCC \>46.182 ng/g). The median values of AL indices were low in both higher and lower HCC groups, as the possible ranges were 0--18. Nevertheless, we found significant differences in cardiovascular and metabolic systems risk scores and multiple systems AL index median (IQR) values between 2 HCC groups. No associations were found between the immune, oxidative stress, and platelet activition systems risk scores median (IQR) values and HCC. The high-risk cut-off point values for individual biomarkers used for AL index calculation are provided in [Table 4](#t4-medscimonit-25-3573){ref-type="table"}. Differences in individual systems risk scores and allostatic load index median (IQR) values according to HCC groups are shown in [Table 5](#t5-medscimonit-25-3573){ref-type="table"}.

Discussion
==========

Although a number of studies have addressed the association between the HCC and individual cardiovascular risk factors, there are limited data describing the relationship between HCC and the number of prevalent cardiovascular risk factors. Thus, the main discovery of our work is the association of higher HCC and the increased number of cardiovascular risk factors, which indicates elevated risk of CVD. These results are in accordance with the evidence of the association of chronic stress (evaluated subjectively using self-reported questionnaires or objectively measuring HCC) and increased risk of CVD \[[@b7-medscimonit-25-3573],[@b29-medscimonit-25-3573],[@b30-medscimonit-25-3573]\]. A previous cross-sectional study Manenschijn et al. \[[@b7-medscimonit-25-3573]\] showed that high hair cortisol concentration (fourth HCC quartile) is associated with a 2.7 times increased CVD risk, including coronary heart disease, stroke, and peripheral arterial disease in community-dwelling elderly participants. Furthermore, the results of a prospective case-control study conducted by Pereg and coworkers \[[@b29-medscimonit-25-3573]\] showed significantly higher HCC in patients with acute myocardial infarction compared with a control group. Similarly, the large case-control INTERHEART \[[@b30-medscimonit-25-3573]\] study reported that presence of subjectively evaluated psychosocial stress, including stress at home or work, financial stress, stressful life events, and depression, is associated with increased risk of myocardial infarction.

The present study also examined the relationship between hair cortisol level and the manifestation of traditional cardiovascular risk factors. We found a positive association of higher HCC with greater-than-recommended BMI and WC values. These findings are in line with a study \[[@b31-medscimonit-25-3573]\] in which obese (BMI ≥30 kg/m^2^) participants had significantly higher mean hair cortisol level than normal-weight (BMI 18.5--25 kg/m^2^) or overweight (BMI 25--29.9 kg/m^2^) participants and subjects with raised WC (≥102 cm in men and ≥88 cm in women), indicating central obesity was associated with elevated HCC compared with participants whose waist circumference was in normal range. In other similar studies \[[@b32-medscimonit-25-3573],[@b33-medscimonit-25-3573]\], the waist-to-hip ratio was determined as an additional anthropometric measure and a positive correlation was found between HCC and waist-to-hip ratio values. Since the biological effect of cortisol is manifested in the accumulation of abdominal fat, the increase in parameters related to body fat distribution, such as waist circumference and waist-to-hip ratio, may be the consequence of chronic cortisol exposure. In addition, a previous study \[[@b34-medscimonit-25-3573]\] examined the association of HCC with the prevalence of metabolic syndrome diagnosed by the increase of 3 or more risk factors, including elevated waist circumference, blood pressure, triacylglycerol, long-term glucose levels, and reduced HDL cholesterol concentration. The authors found that individuals with metabolic syndrome had significantly higher HCC as compared to those without metabolic syndrome. Also, we found a positive association between increased HCC and higher-than-recommended TC and LDL-C concentration values. The existing data on the relationship between dyslipidemia and HCC is controversial. A previous study \[[@b35-medscimonit-25-3573]\], in which healthy subjects and patients with major depression were recruited, showed significant positive correlations between the hair cortisol or cortisone (the inactive form of cortisol) and triacylglycerol levels in blood serum in both study groups, but in our study found no significant differences in HCC between the participants with higher-than-recommended and normal TAG concentrations. In contrast to our study, Stalder et al. \[[@b34-medscimonit-25-3573]\] found no relationship between HCC and lipid metabolism biomarkers such as LDL-C and TAG levels, but discovered a significant negative correlation between HCC and HDL-C level in a large occupational cohort. These inconsistencies may arise from the fact that both genders and participants with a wider range of age were involved in previous studies \[[@b34-medscimonit-25-3573],[@b35-medscimonit-25-3573]\], while the present study was limited to only young and middle-aged men. However, since dyslipidemia is one of the main cardiovascular risk factors, further research is clearly needed for the examination of chronic cortisol exposure and its effect on lipid metabolism.

The results of the present study demonstrate the tendency toward higher HCC in hypertensive subjects compared with non-hypertensive individuals. However, the data on the relationship between arterial blood pressure and hair cortisol level is inconsistent. While some previous research \[[@b34-medscimonit-25-3573],[@b36-medscimonit-25-3573]\] reported a positive association between mean arterial blood pressure or systolic blood pressure and HCC, other studies \[[@b37-medscimonit-25-3573],[@b38-medscimonit-25-3573]\] failed to demonstrate the link between arterial bood pressure and hair cortisol level. In addition, Feller et al. \[[@b32-medscimonit-25-3573]\] found no association of prevalent hypertension (evaluated subjectively by study participants) and HCC. Moreover, they found a negative relationship between objectively measured diastolic blood pressure and HCC. These inconsistent results could be explained by differences in characteristics of the study samples, as some previous studies \[[@b37-medscimonit-25-3573],[@b38-medscimonit-25-3573]\] involved patients with structural heart disease or coronary artery disease, while the present and other similar studies \[[@b34-medscimonit-25-3573],[@b36-medscimonit-25-3573]\] assessed subjects with no current diagnosis of cardiovascular disease.

Our findings also revealed no significant association between smoking status and HCC. Similar results have been reported by a previous study \[[@b34-medscimonit-25-3573]\], but different findings were obtained in another study \[[@b32-medscimonit-25-3573]\] in which higher HCC was observed in current smokers compared with non-smokers. These ambiguous results may arise from the fact that the relationship between cigarette smoking and HCC may be dose- and time-dependent, but these 2 aspects were have not yet been assessed.

It is hypothesized that chronic stress induces long-term cortisol exposure, resulting in glucocorticoid receptor resistance that leads to diminished downregulation of inflammatory processes. The risk of chronic inflammatory diseases such as atherosclerosis is increased when inflammation duration is longer and intensity is elevated \[[@b39-medscimonit-25-3573]\]. Our results indicate a weak but statistically significant correlation between HCC and neutrophil percentage value. This finding may be important, as there is growing evidence that neutrophils take part in the progression of atherosclerosis by forming neutrophil extracellular traps that enhance cytokine production in macrophages and activate T helper 17 cells responsible for maintaining the inflammatory process \[[@b40-medscimonit-25-3573],[@b41-medscimonit-25-3573]\]. Additionally, results in a very recent paper by Penz et al. \[[@b42-medscimonit-25-3573]\] show that the increase in HCC is associated with changes in distribution of leukocytes, resulting in expansion of neutrophils and decrease in lymphocytes and monocytes. Moreover, inflammation-induced synthesis of proinflammatory cytokines derived from monocytes and macrophages enhances the release of CRP, which itself promotes inflammation and atherogenesis \[[@b39-medscimonit-25-3573],[@b43-medscimonit-25-3573]\]. However, we found no correlation between HCC and CRP level in blood serum. Similarly, the association between HCC and a relatively new cardiovascular inflammation biomarker, CypA, was also non-significant.

In this work, chronic stress level was measured using 2 different techniques: HCC measurement and AL index calculation. While determination of HCC represents the activity of the hypothalamic-pituitary-adrenal axis, AL index is a measure of cumulative "wear and tear" on the body caused by the dysregulation of multiple physiological systems (e.g., metabolic, cardiovascular, immune) in response to stressors. The very first technique used for the calculation of allostatic load index containing 10 biomarkers (TC, HDL-C, glycosylated hemoglobin, waist-to-hip ratio, dehydroepiandrosterone sulfate, urinary epinephrine, norepinephrine, and cortisol) was introduced and validated in the MacArthur Study of Successful Aging \[[@b44-medscimonit-25-3573]\]. The ability of allostatic load index to predict negative health outcomes was evaluated over a 2.5-year follow-up in which significantly elevated mortality risk was observed. Also, a more recent study \[[@b25-medscimonit-25-3573]\] showed a high test-retest reliability (intraclass correlation coefficient 0.88) between 2 consecutive days of measurement of 6 different physiological systems representing the AL index. We found significantly increased cardiovascular and metabolic systems risk scores and allostatic load index values in the higher HCC group. This is in line with a study \[[@b25-medscimonit-25-3573]\] in which 18 biomarkers were included in the estimation of AL index, and a moderate correlation between HCC and AL index was observed. We suggest that both techniques could be applied in the assessment of physiological response to long-term stress, since our findings showed a positive association between HCC and AL index values. On the other hand, there are many challenges in using these 2 techniques in chronic stress research. Firstly, different methods are used for the determination of HCC, including enzyme-linked immunoassay, liquid chromatography with fluorescence detection or gas chromatography, and liquid chromatography coupled with mass spectrometry. Secondly, there are many methodological differences regarding the calculation of AL index, including variation in the number and combination of biomarkers and definition of high-risk cut-off point values \[[@b11-medscimonit-25-3573],[@b25-medscimonit-25-3573]--[@b27-medscimonit-25-3573]\].

Conclusions
===========

In conclusion, our findings indicate that higher HCC is significantly associated with the prevalence of some cardiovascular risk factors, such as higher-than-recommended BMI, WC, TC, LDL-C, and non-HDL-C values. Furthermore, greater CVD risk assessed by the number of prevalent cardiovascular risk factors, including smoking, hypertension, and greater-than-recommended WC and LDL-C values, is associated with higher HCC. Finally, our results suggest that both HCC measurement and AL index calculation techniques are valuable for the assessment of chronic stress level. However, there are some methodological considerations (e.g., differences in HCC measurement analytical techniques or AL index calculation algorithms) regarding the use of these methods in chronic stress research. Thus, future studies in this field should focus on the standardization and validation of objective chronic stress evaluation techniques.
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###### 

Sociodemographic and lifestyle characteristics of the study sample.

  Variables                                                                            Median (IQR) or n (%)
  ------------------------------------------------------------------------------------ -----------------------
  Age (years)                                                                          39 (16.5)
  Marital status[\*](#tfn1-medscimonit-25-3573){ref-type="table-fn"}                   
   Married                                                                             115 (71.9%)
   Single/divorced/widowed                                                             45 (28.1%)
  Income[\*](#tfn1-medscimonit-25-3573){ref-type="table-fn"}                           
   Lower than national average monthly wage                                            25 (15.6%)
   Equal to or higher than national average monthly wage                               135 (84.4%)
  Additional job[\*](#tfn1-medscimonit-25-3573){ref-type="table-fn"}                   
   Yes                                                                                 39 (24.4%)
   No                                                                                  121 (75.6%)
  Night job[\*](#tfn1-medscimonit-25-3573){ref-type="table-fn"}                        
   Yes                                                                                 20 (12.5%)
   No                                                                                  140 (87.5%)
  Smoking status[\*](#tfn1-medscimonit-25-3573){ref-type="table-fn"}                   
   Smoker                                                                              27 (16.9%)
   Non-smoker                                                                          133 (83.1%)
  Physical activity at work[\*](#tfn1-medscimonit-25-3573){ref-type="table-fn"}        
   Inactive                                                                            111 (69.4%)
   Active                                                                              49 (30.6%)
  Leisure-time physical activity[\*](#tfn1-medscimonit-25-3573){ref-type="table-fn"}   
   Inactive                                                                            29 (18.2%)
   Active                                                                              130 (81.8%)

Variable has missing data.

###### 

Anthropometric, cardiometabolic indicators, neuroendocrine, inflammation, oxidative stress, and platelet activation biomarkers of the study sample.

  Variables                                            Mean ±SD or median (IQR)   Range
  ---------------------------------------------------- -------------------------- ----------------
  Anthropometric and cardiometabolic indicators                                   
   Weight (kg)                                         84.20 (17.05)              54.30--178.00
   Height (cm)                                         183.06±6.33                166.00--198.50
   Body mass index (kg/m^2^)                           25.04 (4.75)               16.95--45.40
   Waist circumference (cm)                            89 (15)                    69--141
   Resting systolic blood pressure (mmHg)              129 (16.5)                 93--175
   Resting diastolic blood pressure (mmHg)             76 (13)                    57--104
   Resting heart rate (bpm)                            63 (14)                    40--94
   Fasting glucose (mmol/l)                            5.24 (0.52)                4.15--7.61
   Total cholesterol (mmol/l)                          5.02 (1.39)                3.04--8.73
   High-density lipoprotein cholesterol (mmol/l)       1.19 (0.33)                0.58--2.21
   Low-density lipoprotein cholesterol (mmol/l)        3.11 (1.17)                1.56--5.95
   Non-high-density lipoprotein cholesterol (mmol/l)   3.78 (1.49)                1.99--7.61
   Triacylglycerols (mmol/l)                           1.17 (0.86)                0.41--9.94
  Neuroendocrine biomarker                                                        
   Hair cortisol (ng/g)                                46.18 (119.29)             0.63--858.31
  Inflammation biomarkers                                                         
   C-reactive protein (mg/l)                           0.64 (0.96)                0.10--31.00
   Cyclophilin A (ng/ml)                               43.52 (60.20)              0.33--81.00
   WBC count (10^9^/l)                                 5.47 (1.52)                2.82--9.45
   Neutrophil percentage (%)                           47.96±8.33                 29.18--73.31
  Oxidative stress biomarkers                                                     
   Malondialdehyde (μg/l)                              97.48 (35.62)              56.03--251.42
   Ferric reducing ability of plasma (μmol Fe^2+^/l)   47.67 (11.41)              28.50--79.98
  Platelet activation biomarkers                                                  
   CD63+ platelets stimulated with TRAP (%)            28.85 (21.05)              0.40--69.20
   PAC-1 + platelets stimulated with ADP (%)           49.40 (37.20)              0.10--90.20

###### 

Correlations between hair cortisol concentration and inflammation, oxidative stress, and platelet activation biomarkers.

  Variables                                           Spearman's r   *p*-value
  --------------------------------------------------- -------------- -----------
  C-reactive protein (mg/l)                           0.108          0.171
  Cyclophilin A (ng/ml)                               0.090          0.260
  WBC count (10^9^/l)                                 0.089          0.262
  Neutrophil percentage (%)                           0.197          **0.012**
  Malondialdehyde (μg/l)                              0.087          0.301
  Ferric reducing ability of plasma (μmol Fe^2+^/l)   0.102          0.203
  CD63+ platelets stimulated with TRAP (%)            0.066          0.416
  PAC-1 + platelets stimulated with ADP (%)           −0.018         0.840

###### 

High-risk cut-off point values of individual biomarkers used in calculating the allostatic load index.

  System                                                                                          Biomarker                                                                                      n        High-risk cut-off point
  ----------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- -------- -------------------------
  Cardiovascular                                                                                  Resting SBP (mmHg)                                                                             163      ≥136
  Resting DBP (mmHg)                                                                              163                                                                                            ≥83      
  Resting heart rate (bpm)                                                                        163                                                                                            ≥71      
  Metabolic                                                                                       BMI(kg/m^2^)                                                                                   163      ≥27.91
  WC (cm)[\*](#tfn2-medscimonit-25-3573){ref-type="table-fn"}                                     162                                                                                            ≥98      
  Fasting glucose (mmol/l)                                                                        163                                                                                            ≥5.50    
  Triacylglycerols (mmol/l)                                                                       163                                                                                            ≥1.74    
  HDL cholesterol (mmol/l)                                                                        163                                                                                            ≤1.055   
  LDL cholesterol (mmol/l)                                                                        163                                                                                            ≥3.79    
  Total cholesterol (mmol/l)                                                                      163                                                                                            ≥5.83    
  Immune                                                                                          CRP (mg/l)[\*](#tfn2-medscimonit-25-3573){ref-type="table-fn"}                                 162      ≥1.30
  Neutrophil percentage (%)[\*](#tfn2-medscimonit-25-3573){ref-type="table-fn"}                   161                                                                                            ≥52.81   
  WBC(109/l)[\*](#tfn2-medscimonit-25-3573){ref-type="table-fn"}                                  161                                                                                            ≥6.28    
  CypA (ng/ml)[\*](#tfn2-medscimonit-25-3573){ref-type="table-fn"}                                160                                                                                            ≥81.00   
  Oxidative stress                                                                                MDA (μg/l)[\*](#tfn2-medscimonit-25-3573){ref-type="table-fn"}                                 142      ≥119.30
  FRAP (μmol Fe^2+^/l)[\*](#tfn2-medscimonit-25-3573){ref-type="table-fn"}                        158                                                                                            ≤42.92   
  Platelet activation                                                                             CD63+ platelets stimulated with TRAP (%)[\*](#tfn2-medscimonit-25-3573){ref-type="table-fn"}   152      ≥40.35
  PAC-1 + platelets stimulated with ADP (%)[\*](#tfn2-medscimonit-25-3573){ref-type="table-fn"}   129                                                                                            ≥66.40   

Variable has missing data.

###### 

Differences in individual systems' risk scores and allostatic load index values according to hair cortisol concentration groups.

  Variable                  Median (IQR)   *p*-value   
  ------------------------- -------------- ----------- -----------
  SRS (cardiovascular)      0 (1)          1 (2)       **0.028**
  SRS (metabolic)           1 (2)          2 (3)       **0.009**
  SRS (immune)              1 (1)          1 (2)       0.135
  SRS (oxidative stress)    0 (1)          1 (1)       0.243
  SRS (platelet activity)   0.5 (1)        0.5 (1)     0.138
  AL index                  3.5 (3)        5 (3)       **0.004**
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